These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related]
4. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
5. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers. Mahendra BJ; Madhusudana SN; Ashwathnarayana DH; Sampath G; datta SS; Sudarshan MK; Venkatesh GM; Muhamuda K; Bilagumba G; Shamanna M Vaccine; 2007 Dec; 25(50):8405-9. PubMed ID: 17981377 [TBL] [Abstract][Full Text] [Related]
6. Intradermal immunization with human diploid cell rabies vaccine. Serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine. Burridge MJ; Baer GM; Sumner JW; Sussman O JAMA; 1982 Oct; 248(13):1611-4. PubMed ID: 7109184 [TBL] [Abstract][Full Text] [Related]
7. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule]. Landry P; Lazzaro M; Darioli R Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997 [TBL] [Abstract][Full Text] [Related]
8. [Attempts at postexposure active and passive human rabies immunization]. Keller H; Hauser R; Wandeler A; Steck F Schweiz Med Wochenschr; 1977 Dec; 107(49):1857-9. PubMed ID: 73219 [TBL] [Abstract][Full Text] [Related]
9. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
10. Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine. Horman JT; Rullán JV; Myers RA; Bond JO; Israel E; Joseph JM J Am Vet Med Assoc; 1987 Jul; 191(2):185-7. PubMed ID: 3610792 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value]. Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019 [TBL] [Abstract][Full Text] [Related]
12. [Immunogenicity of a new, highly purified, highly concentrated duck-embryo rabies vaccine]. Keller H; Glück R; Wegmann A; Wandeler AI Schweiz Med Wochenschr; 1984 May; 114(19):648-53. PubMed ID: 6740281 [TBL] [Abstract][Full Text] [Related]
13. Intradermal pre-exposure rabies immunisation in New Zealand. Shaw MM; Leggat PA; Williams ML Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722 [TBL] [Abstract][Full Text] [Related]
14. A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children. Sabchareon A; Lang J; Attanath P; Sirivichayakul C; Pengsaa K; Le Mener V; Chantavanich P; Prarinyanuphab V; Pojjaroen-Anant C; Nimnual S; Wood SC; Riffard P Clin Infect Dis; 1999 Jul; 29(1):141-9. PubMed ID: 10433577 [TBL] [Abstract][Full Text] [Related]
15. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV). Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Matha IS; Salunke SR Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086 [TBL] [Abstract][Full Text] [Related]
17. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers". Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424 [TBL] [Abstract][Full Text] [Related]
18. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals]. Baysal B; Tosun S; Ozdemir M; Doğan M Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389 [TBL] [Abstract][Full Text] [Related]